The epidemiology of atypical chronic lung disease in extremely low birth weight infants

Journal of Perinatology

Volumn 28, Issue 2, 2008, Pages 141-148

  Streubel, A H ^a,b   Donohue, P K ^a,c   Aucott, S W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BERACTANT; INDOMETACIN; LUNG SURFACTANT; OXYGEN;

ARTERY LIGATION; ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFECTION RISK; LEUKOMALACIA; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG EDEMA; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PNEUMOTHORAX; PREMATURITY; RISK ASSESSMENT; RISK FACTOR; SEPSIS;

BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; FEMALE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LENGTH OF STAY; LUNG DISEASES; MALE; OXYGEN; PNEUMOTHORAX; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES;

EID: 38949104112     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211894     Document Type: Article

References (10)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of membrane disease. N Engl J Med 1967; 276: 357-368.
2. Hudak BB, Egan EA. impact of lung surfactant therapy on chronic lung diseases in premature infants. Clin Perinal 1992; 19: 591-602.
3. Jobe AH, Bancalari E. NICHD/NHLBI/ORF workshop summary: Bronchopulmonary dysplasia. Am J Respir Crit Car Med 2001; 163: 1723-1729.
4. Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999; 103: 759-765.
5. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatrics 1995; 126: 605-610.
6. Palta M, Gabbert D, Weinstein MR, Peters ME. Multivariale assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Fediatrics 1991; 119: 285-292.
7. Van Iierde S, Smith J, Devlieger H, Eggermont E. Outcome of respiratory distress syndrome at 28 days: A prospective longitudinal study. Eur Resp J 1992; 5: 1243-1248.
8. Panikar J, Scholefield H, Kumar Y, Pilling DW, Subhedar NV. Atypical lung disease in preterm infants. JPerinat Med 2004; 32: 162-167.
9. Holtzman RB, Hageman JR, Yogev R. Role of ureaplasma urealyticum in bronchopulmonary dysplasia. J Pediatrics 1989; L14: 1061-1063.
10. Van Marter LJ, Danmann O, Allred EN, Leviton A, Pagano M, Moore M et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatrics 2002; 140: 171-176.